Compare CALM & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CALM | OPCH |
|---|---|---|
| Founded | 1957 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Medical/Nursing Services |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.5B |
| IPO Year | 1996 | 1996 |
| Metric | CALM | OPCH |
|---|---|---|
| Price | $80.77 | $20.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $92.00 | $36.57 |
| AVG Volume (30 Days) | 732.7K | ★ 2.9M |
| Earning Date | 04-01-2026 | 04-30-2026 |
| Dividend Yield | ★ 11.13% | N/A |
| EPS Growth | ★ 338.49 | 3.25 |
| EPS | ★ 7.34 | 0.29 |
| Revenue | $1,351,609,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | N/A | $7.21 |
| Revenue Next Year | N/A | $8.55 |
| P/E Ratio | ★ $10.81 | $73.55 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $71.92 | $18.01 |
| 52 Week High | $126.40 | $36.80 |
| Indicator | CALM | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 57.45 | 44.65 |
| Support Level | $73.42 | $19.61 |
| Resistance Level | $83.83 | $22.25 |
| Average True Range (ATR) | 2.30 | 0.72 |
| MACD | 0.22 | 0.10 |
| Stochastic Oscillator | 89.53 | 21.31 |
Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.